drugset / Trial / NCT01222650

A Comparative Study of KSO-0400 in BPH Patients With LUTS

NCT01222650

Phase 2 Completed 400 enrolled Kissei Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is to evaluate the efficacy and safety of KSO-0400 compared to placebo for the treatment of LUTS caused by BPH.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject KSO-0400 Unknown
Subject Silodosin Unknown